CADL, NGM
Candel Therapeutics, Inc. (CADL)
Price (as of October 28)
1.94USD
Correlations
Lowest within Industry
Symbol | Correlation |
---|---|
First Wave BioPharma, Inc. |
-0.26 |
ADMA Biologics, Inc. |
-0.25 |
Frequency Therapeutics, Inc. |
-0.23 |
CRISPR Therapeutics AG |
-0.2 |
Alpine Immune Sciences, Inc. |
-0.2 |
Adicet Bio, Inc. |
-0.02 |
Abeona Therapeutics Inc. |
0.01 |
Inozyme Pharma, Inc. |
-0.02 |
Akouos, Inc. |
-0.03 |
HCW Biologics Inc. |
-0.13 |
Highest within Industry
Symbol | Correlation |
---|---|
Immunovant, Inc. |
0.28 |
ERYTECH Pharma S.A. |
0.27 |
Genprex, Inc. |
0.27 |
Epizyme, Inc. |
0.26 |
Alzamend Neuro, Inc. |
0.26 |
Harpoon Therapeutics, Inc. |
0.1 |
Forte Biosciences, Inc. |
0.02 |
Clearside Biomedical, Inc. |
0 |
Enanta Pharmaceuticals, Inc. |
0.05 |
Caladrius Biosciences, Inc. |
0.01 |
Lowest within Industry
Symbol | Correlation |
---|---|
Corvus Pharmaceuticals, Inc. |
-0.18 |
First Wave BioPharma, Inc. |
-0.16 |
CRISPR Therapeutics AG |
-0.15 |
HCW Biologics Inc. |
-0.13 |
Champions Oncology, Inc. |
-0.1 |
CinCor Pharma, Inc. |
-0.09 |
Entasis Therapeutics Holdings Inc. |
-0.09 |
Finch Therapeutics Group, Inc. |
-0.09 |
AgeX Therapeutics, Inc. |
-0.11 |
Compass Therapeutics, Inc. |
-0.09 |
Highest within Industry
Symbol | Correlation |
---|---|
Galapagos NV |
0.19 |
Erasca, Inc. |
0.15 |
ERYTECH Pharma S.A. |
0.12 |
ALX Oncology Holdings Inc. |
0.11 |
Aeglea BioTherapeutics, Inc. |
0.11 |
HOOKIPA Pharma Inc. |
0.11 |
CorMedix Inc. |
0.1 |
Harpoon Therapeutics, Inc. |
0.1 |
Allogene Therapeutics, Inc. |
0.09 |
GreenLight Biosciences Holdings |
0.1 |
Lowest within Industry
Symbol | Correlation |
---|---|
Corvus Pharmaceuticals, Inc. |
-0.18 |
First Wave BioPharma, Inc. |
-0.16 |
CRISPR Therapeutics AG |
-0.15 |
HCW Biologics Inc. |
-0.13 |
AgeX Therapeutics, Inc. |
-0.11 |
Champions Oncology, Inc. |
-0.1 |
CinCor Pharma, Inc. |
-0.09 |
Entasis Therapeutics Holdings Inc. |
-0.09 |
Finch Therapeutics Group, Inc. |
-0.09 |
ARCA biopharma, Inc. |
-0.09 |
Highest within Industry
Symbol | Correlation |
---|---|
Galapagos NV |
0.19 |
Erasca, Inc. |
0.15 |
ERYTECH Pharma S.A. |
0.12 |
HOOKIPA Pharma Inc. |
0.11 |
CorMedix Inc. |
0.1 |
Aeglea BioTherapeutics, Inc. |
0.1 |
Harpoon Therapeutics, Inc. |
0.1 |
GreenLight Biosciences Holdings |
0.1 |
Graphite Bio, Inc. |
0.09 |
ALX Oncology Holdings Inc. |
0.09 |
Lowest within Industry
Symbol | Correlation |
---|---|
Corvus Pharmaceuticals, Inc. |
-0.18 |
First Wave BioPharma, Inc. |
-0.16 |
CRISPR Therapeutics AG |
-0.15 |
HCW Biologics Inc. |
-0.13 |
AgeX Therapeutics, Inc. |
-0.11 |
Champions Oncology, Inc. |
-0.1 |
CinCor Pharma, Inc. |
-0.09 |
Entasis Therapeutics Holdings Inc. |
-0.09 |
Finch Therapeutics Group, Inc. |
-0.09 |
ARCA biopharma, Inc. |
-0.09 |
Highest within Industry
Symbol | Correlation |
---|---|
Galapagos NV |
0.19 |
Erasca, Inc. |
0.15 |
ERYTECH Pharma S.A. |
0.12 |
HOOKIPA Pharma Inc. |
0.11 |
CorMedix Inc. |
0.1 |
Aeglea BioTherapeutics, Inc. |
0.1 |
Harpoon Therapeutics, Inc. |
0.1 |
GreenLight Biosciences Holdings |
0.1 |
Graphite Bio, Inc. |
0.09 |
ALX Oncology Holdings Inc. |
0.09 |
Lowest by Sector
Symbol | Correlation |
---|---|
Addus HomeCare Corporation |
-0.32 |
First Wave BioPharma, Inc. |
-0.26 |
ADMA Biologics, Inc. |
-0.25 |
Inspire Medical Systems, Inc. |
-0.25 |
Frequency Therapeutics, Inc. |
-0.23 |
Genetron Holdings Limited |
-0.01 |
Encompass Health Corporation |
-0.08 |
AdaptHealth Corp. |
-0.03 |
CRISPR Therapeutics AG |
-0.15 |
Alpine Immune Sciences, Inc. |
-0.03 |
Highest by Sector
Symbol | Correlation |
---|---|
Adamis Pharmaceuticals Corporation |
0.35 |
Global Cord Blood Corporation |
0.33 |
Immunovant, Inc. |
0.28 |
ERYTECH Pharma S.A. |
0.27 |
High Tide Inc. |
0.27 |
Genprex, Inc. |
0.03 |
Epizyme, Inc. |
0.04 |
Alzamend Neuro, Inc. |
0.06 |
Harpoon Therapeutics, Inc. |
0.1 |
electroCore, Inc. |
0.08 |
Lowest by Sector
Symbol | Correlation |
---|---|
Corvus Pharmaceuticals, Inc. |
-0.18 |
First Wave BioPharma, Inc. |
-0.16 |
CRISPR Therapeutics AG |
-0.15 |
HCW Biologics Inc. |
-0.13 |
Dynavax Technologies Corporation |
-0.12 |
Charles River Laboratories International, Inc. |
-0.11 |
Addus HomeCare Corporation |
-0.08 |
Champions Oncology, Inc. |
-0.1 |
CinCor Pharma, Inc. |
-0.09 |
Entasis Therapeutics Holdings Inc. |
-0.09 |
Highest by Sector
Symbol | Correlation |
---|---|
Galapagos NV |
0.19 |
Adamis Pharmaceuticals Corporation |
0.18 |
Computer Programs and Systems, Inc. |
0.16 |
Erasca, Inc. |
0.15 |
Global Cord Blood Corporation |
0.13 |
ERYTECH Pharma S.A. |
0.12 |
Femasys Inc. |
0.12 |
ALX Oncology Holdings Inc. |
0.09 |
Aeglea BioTherapeutics, Inc. |
0.1 |
HOOKIPA Pharma Inc. |
0.11 |
Lowest by Sector
Symbol | Correlation |
---|---|
Corvus Pharmaceuticals, Inc. |
-0.18 |
First Wave BioPharma, Inc. |
-0.16 |
CRISPR Therapeutics AG |
-0.15 |
HCW Biologics Inc. |
-0.13 |
Dynavax Technologies Corporation |
-0.12 |
Charles River Laboratories International, Inc. |
-0.11 |
AgeX Therapeutics, Inc. |
-0.11 |
Champions Oncology, Inc. |
-0.1 |
CinCor Pharma, Inc. |
-0.09 |
Entasis Therapeutics Holdings Inc. |
-0.09 |
Highest by Sector
Symbol | Correlation |
---|---|
Galapagos NV |
0.19 |
Computer Programs and Systems, Inc. |
0.16 |
Erasca, Inc. |
0.15 |
Global Cord Blood Corporation |
0.13 |
ERYTECH Pharma S.A. |
0.12 |
Femasys Inc. |
0.12 |
Adamis Pharmaceuticals Corporation |
0.11 |
HOOKIPA Pharma Inc. |
0.11 |
CorMedix Inc. |
0.1 |
Aeglea BioTherapeutics, Inc. |
0.1 |
Lowest by Sector
Symbol | Correlation |
---|---|
Corvus Pharmaceuticals, Inc. |
-0.18 |
First Wave BioPharma, Inc. |
-0.16 |
CRISPR Therapeutics AG |
-0.15 |
HCW Biologics Inc. |
-0.13 |
Dynavax Technologies Corporation |
-0.12 |
Charles River Laboratories International, Inc. |
-0.11 |
AgeX Therapeutics, Inc. |
-0.11 |
Champions Oncology, Inc. |
-0.1 |
CinCor Pharma, Inc. |
-0.09 |
Entasis Therapeutics Holdings Inc. |
-0.09 |
Highest by Sector
Symbol | Correlation |
---|---|
Galapagos NV |
0.19 |
Computer Programs and Systems, Inc. |
0.16 |
Erasca, Inc. |
0.15 |
Global Cord Blood Corporation |
0.13 |
ERYTECH Pharma S.A. |
0.12 |
Femasys Inc. |
0.12 |
Adamis Pharmaceuticals Corporation |
0.11 |
HOOKIPA Pharma Inc. |
0.11 |
CorMedix Inc. |
0.1 |
Aeglea BioTherapeutics, Inc. |
0.1 |
Lowest Overall
Symbol | Correlation |
---|---|
Albertsons Companies, Inc. |
-0.45 |
ABG Acquisition Corp. I |
-0.43 |
Direct Selling Acquisition Corp. |
-0.42 |
Inception Growth Acquisition Limited |
-0.4 |
Flexsteel Industries, Inc. |
-0.39 |
First Interstate BancSystem, Inc. |
-0.04 |
Clearwater Paper Corporation |
-0.07 |
iShares MSCI Peru ETF |
-0.13 |
1-800-FLOWERS.COM, Inc. |
0 |
Foot Locker, Inc. |
0.01 |
Highest Overall
Symbol | Correlation |
---|---|
ALSP Orchid Acquisition Corporation I |
0.68 |
Apollo Investment Corporation |
0.45 |
Adit EdTech Acquisition Corp. |
0.39 |
Gold Fields Limited |
0.36 |
Adamis Pharmaceuticals Corporation |
0.35 |
Eagle Bancorp, Inc. |
0.12 |
Entravision Communications Corporation |
0.14 |
Global Cord Blood Corporation |
0.13 |
American National Group, Inc. |
-0.07 |
EZFill Holdings Inc. |
0.07 |
Lowest Overall
Symbol | Correlation |
---|---|
SOAR Technology Acquisition Corp. |
-0.23 |
Inception Growth Acquisition Limited |
-0.22 |
Dakota Gold Corp. |
-0.21 |
Atlas Crest Investment Corp. II |
-0.2 |
5E Advanced Materials Inc. |
-0.2 |
Freshpet, Inc. |
-0.2 |
Corvus Pharmaceuticals, Inc. |
-0.18 |
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares |
-0.18 |
East Stone Acquisition Corporation |
-0.18 |
Harte Hanks, Inc. |
-0.17 |
Highest Overall
Symbol | Correlation |
---|---|
ALSP Orchid Acquisition Corporation I |
0.35 |
FGI Industries Ltd. |
0.24 |
European Biotech Acquisition Corp. |
0.23 |
GoHealth, Inc. |
0.2 |
Rareview Inflation/Deflation ETF |
0.19 |
Galapagos NV |
0.19 |
Adamis Pharmaceuticals Corporation |
0.11 |
AssetMark Financial Holdings, Inc. |
0.17 |
Ameriprise Financial, Inc. |
0.15 |
FinTech Acquisition Corp. VI |
0.17 |
Lowest Overall
Symbol | Correlation |
---|---|
SOAR Technology Acquisition Corp. |
-0.23 |
Inception Growth Acquisition Limited |
-0.22 |
Dakota Gold Corp. |
-0.21 |
5E Advanced Materials Inc. |
-0.2 |
Freshpet, Inc. |
-0.2 |
Corvus Pharmaceuticals, Inc. |
-0.18 |
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares |
-0.18 |
East Stone Acquisition Corporation |
-0.18 |
Harte Hanks, Inc. |
-0.17 |
Optica Rare Earths & Critical Materials ETF |
-0.17 |
Highest Overall
Symbol | Correlation |
---|---|
ALSP Orchid Acquisition Corporation I |
0.35 |
FGI Industries Ltd. |
0.24 |
European Biotech Acquisition Corp. |
0.23 |
GoHealth, Inc. |
0.2 |
Rareview Inflation/Deflation ETF |
0.19 |
Galapagos NV |
0.19 |
AssetMark Financial Holdings, Inc. |
0.17 |
FinTech Acquisition Corp. VI |
0.17 |
INVESCO CHINA SMALL CAP ETF |
0.17 |
RH Hedged Multi-Asset Income ETF |
0.16 |
Lowest Overall
Symbol | Correlation |
---|---|
SOAR Technology Acquisition Corp. |
-0.23 |
Inception Growth Acquisition Limited |
-0.22 |
Dakota Gold Corp. |
-0.21 |
5E Advanced Materials Inc. |
-0.2 |
Freshpet, Inc. |
-0.2 |
Corvus Pharmaceuticals, Inc. |
-0.18 |
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares |
-0.18 |
East Stone Acquisition Corporation |
-0.18 |
Harte Hanks, Inc. |
-0.17 |
Optica Rare Earths & Critical Materials ETF |
-0.17 |
Highest Overall
Symbol | Correlation |
---|---|
ALSP Orchid Acquisition Corporation I |
0.35 |
FGI Industries Ltd. |
0.24 |
European Biotech Acquisition Corp. |
0.23 |
GoHealth, Inc. |
0.2 |
Rareview Inflation/Deflation ETF |
0.19 |
Galapagos NV |
0.19 |
AssetMark Financial Holdings, Inc. |
0.17 |
FinTech Acquisition Corp. VI |
0.17 |
INVESCO CHINA SMALL CAP ETF |
0.17 |
RH Hedged Multi-Asset Income ETF |
0.16 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.